Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implicationsVictoria Abbing‐Karahagopian, Marie L. De Bruin, Consuelo Huerta et al.|European Journal of Clinical Pharmacology|2014Cited by 162
Antibiotic prescribing for children in primary care and adherence to treatment guidelinesVerica Ivanovska, Liset van Dijk, Aukje K. Mantel Teeuwisse et al.|Journal of Antimicrobial Chemotherapy|2016Cited by 74
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosisEnrico Costa, Marco Cipolli, Silvia Girotti et al.|Orphanet Journal of Rare Diseases|2022Cited by 51
Uptake of orphan drugs in the WHO essential medicines listsEnrico Costa, Hubert G. M. Leufkens, Lorenzo Moja et al.|Bulletin of the World Health Organization|2024Cited by 16
Successes and pitfalls in orphan drug development for sickle cell diseaseEnrico Costa, Lucia De Franceschi, Antonella Isgrò et al.|Blood Advances|2024Cited by 16